Tumor growth suppression using a combination of taxol-based therapy and GSK3 inhibition in non-small cell lung cancer

Glycogen synthase kinase-3 (GSK3) is over-expressed and hyperactivated in non-small cell lung carcinoma (NSCLC) and plays a role in ensuring the correct alignment of chromosomes on the metaphase plate during mitosis through regulation of microtubule stability. This makes the enzyme an attractive tar...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Flaherty, Linda, Shnyder, Steven D., Cooper, Patricia A., Cross, Stephen J., Wakefield, James G., Pardo, Olivier E., Seckl, Michael J., Tavaré, Jeremy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457575/
https://www.ncbi.nlm.nih.gov/pubmed/30969984
http://dx.doi.org/10.1371/journal.pone.0214610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457575/
https://www.ncbi.nlm.nih.gov/pubmed/30969984
http://dx.doi.org/10.1371/journal.pone.0214610

Ejemplares similares